Authors: FARRER LA CUPPLES LA VANDUIJN CM KURZ A ZIMMER R MULLER U GREEN RC CLARKE V SHOFFNER R WALLACE DC CHUI H FLANAGAN SD DUARA R STGEORGEHYSLOP P AUERBACH SA VOLICER L WELLS JM VANBROECKHOVEN C GROWDON JH HAINES JL

Citation: La. Farrer et al., APOLIPOPROTEIN-E GENOTYPE IN PATIENTS WITH ALZHEIMERS-DISEASE - IMPLICATIONS FOR THE RISK OF DEMENTIA AMONG RELATIVES, Annals of neurology, 38(5), 1995, pp. 797-808

Authors: COMINGS DE MUHLEMAN D AHN C GYSIN R FLANAGAN SD

Citation: De. Comings et al., THE DOPAMINE-D(2) RECEPTOR GENE - A GENETIC RISK FACTOR IN SUBSTANCE-ABUSE, Drug and alcohol dependence, 34(3), 1994, pp. 175-180

Authors: SLATKIN NE FLANAGAN SD BUZIN C GYSIN R

Citation: Ne. Slatkin et al., GENETIC-FACTORS IN PARKINSONS AGE-OF-ONSET - VARIANTS AT THE CYTOCHROME-P-450 II-D6 LOCUS, Neurology, 44(4), 1994, pp. 10000155-10000155

Authors: COMINGS DE FLANAGAN SD DIETZ G MUHLEMAN D KNELL E GYSIN R

Citation: De. Comings et al., THE DOPAMINE-D(2) RECEPTOR (DRD2) AS A MAJOR GENE IN OBESITY AND HEIGHT, Biochemical medicine and metabolic biology, 50(2), 1993, pp. 176-185